Advertisement

Epigenetics Armed German E. coli

The 2011 outbreak in Germany that caused some 50 deaths was caused by a strain of E. coli with a complex mechanism of gene regulation.

By | November 9, 2012

Falsely colored E. coliWikimedia, MattosaurusEpigenetics may hold the answer to the virulent strain of E. coli that swept across Germany in May and June 2011, causing thousands of infections and dozens of deaths, according to a study published yesterday (November 8) in Nature Biotechnology.

At the time of the outbreak, researchers around the world worked furiously to sequence the genome of the unknown E. coli strain and identify its virulence secrets. The experience was a testament to the power of current sequencing technologies—allowing researchers to achieve a complete genome sequence within just 3 days—but it also showed its limitations. The genome sequence alone could not explain the fast and furious outbreak.

To get to the bottom of the mystery, Eric Schadt, director of Mount Sinai’s Institute for Genomics and Multiscale Biology, and colleagues at Harvard Medical School took a second look at the genome, this time focusing not on the base pairs themselves, but on their epigenetic marks. “The information content of the genetic code is not limited to the primary nucleotide sequence of As, Gs, Cs and Ts,” Schadt said in a press release.  “Without genome-wide DNA base modification information, you simply don’t have a complete picture of all the variation and the phenotypic variability that we see.”

Sure enough, the team found some 50,000 methyl-carrying adenine (A) bases throughout the E. coli genome. They further identified a group of enzymes, including some that are new to science, that target the adenines of different DNA motifs, such as GATC and ACCACC. The group further showed that such epigenetic modifications affected the expression of a wide range of genes, particularly those involved in cellular pathways linked to bacterial growth and motility. One motif— CTGCAG—was specific to the outbreak E. coli strain, suggesting it played a role in the bacterium’s high level of virulence. Indeed, knocking out the methylase that targeted this motif caused structural changes in the genome that could affect virulence and pathogenicity.

“The DNA bases targeted for modification are highly non-random, and the targeting had a broad effect on the transcription of genes,” Schadt said in the release. “It almost appears like another language.”

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Hugh-F-61

Hugh-F-61

Posts: 67

November 12, 2012

CTGCAG is the recognotion site for restriction enzyme Pst1. If the virulent E.coli has picked up new methylation genes from another species it may have picked up a virulence gene too. The CTGCAG methylase may just be hitch hiking. If knocking it out changes things, there must be other CTGCAG recognition proteins there that don't bind when the sequence is methylated. A CTGCAG affinity column protein preparation is called for.

Restriction enzymes are usually antiviral devices.  

Avatar of: Hugh-F-61

Hugh-F-61

Posts: 67

November 12, 2012

Apologies, The original article does say the virulence was due to Shiga toxin from the same phage as the methyltransferase.

Avatar of: Kenneth Y.A.B

Kenneth Y.A.B

Posts: 2

Replied to a comment from Hugh-F-61 made on November 12, 2012

November 13, 2012

That's what I thought initially.

Advertisement
BD Biosciences
BD Biosciences

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  3. Biologist Resigns Amid Sexual Misconduct Probe
  4. Turning Tumor Cells Against Cancer
Advertisement
Lexogen
Lexogen
Advertisement
Life Technologies